Mission Seeking to Bring New Options to Patients with Blood Cancers
Description We are a Seattle based biopharmaceutical company focused on the development and commercialization of novel therapies that address unique unmet medical needs for patients suffering from blood-related cancers. Pacritinib, our lead product candidate is in development for the treatment of myelofibrosis which has the potential to fulfill a significant treatment gap in the management of these patients due to it’s unique clinical profile.
CTI BioPharma has an employee rating of 3.9 out of 5 stars, based on 18 company reviews on Glassdoor which indicates that most employees have a good working experience there. The CTI BioPharma employee rating is in line with the average (within 1 standard deviation) for employers within the Pharmaceutical & Biotechnology industry (3.5 stars).
Overall, 62% of employees would recommend working at CTI BioPharma to a friend. This is based on 18 anonymously submitted reviews on Glassdoor.
67% of job seekers rate their interview experience at CTI BioPharma as positive. Candidates give an average difficulty score of 3 out of 5 (where 5 is the highest level of difficulty) for their job interview at CTI BioPharma.